XML 38 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Results (unaudited) (Tables)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Schedule of effect of revisions to statement of operations and cash flows
The effect of the revisions to the consolidated statements of cash flows is as follows for the years ended December 31, 2012 and 2011 (in thousands):

 
2012
 
2011
 
As Previously Reported
 
Adjustment
 
As Revised
 
As Previously Reported
 
Adjustment
 
As Revised
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
 
Changes in operating assets and liabilities, net of effects from acquisitions:
 
 
 
 
 
 
 
 
 
 
 
Prepaid expenses and other current assets
$
6,066

 
$
291

 
$
6,357

 
$
(7,014
)
 
$
2,186

 
$
(4,828
)
Accounts payable and accrued expenses
59,653

 
(981
)
 
58,672

 
15,184

 
(7,970
)
 
7,214

Other non-current assets and liabilities
(4,070
)
 
305

 
(3,765
)
 
8,704

 
(493
)
 
8,211

Net cash provided by operating activities
530,405

 
(385
)
 
530,020

 
452,555

 
(6,277
)
 
446,278

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Purchases of property and equipment
(165,642
)
 
(1,131
)
 
(166,773
)
 
(140,218
)
 
6,773

 
(133,445
)
Other non-current assets and liabilities
(250
)
 
1,062

 
812

 
272

 
(546
)
 
(274
)
Net cash (used in) provided by investing activities
(779,041
)
 
(69
)
 
(779,110
)
 
171,123

 
6,227

 
177,350

Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Proceeds related to the issuance of common stock under stock plans
44,660

 
454

 
45,114

 
25,252

 
50

 
25,302

Net cash used in financing activities
(108,483
)
 
454

 
(108,029
)
 
(294,088
)
 
50

 
(294,038
)
Net (decrease) increase in cash and cash equivalents
(357,208
)
 

 
(357,208
)
 
327,331

 

 
327,331

The effect of the revisions to the consolidated statements of operations is as follows for the years ended December 31, 2012 and 2011 (in thousands):

 
2012
 
2011
 
As Previously Reported
 
Adjustment
 
As Revised
 
As Previously Reported
 
Adjustment
 
As Revised
Cost of revenue
$
431,911

 
$
97,989

 
$
529,900

 
$
374,543

 
$
79,162

 
$
453,705

Research and development
74,744

 

 
74,744

 
52,333

 

 
52,333

Sales and marketing
304,404

 
(81,056
)
 
223,348

 
227,331

 
(64,314
)
 
163,017

General and administrative
227,033

 
(16,933
)
 
210,100

 
191,726

 
(14,848
)
 
176,878

Amortization of acquired intangible assets
20,962

 

 
20,962

 
17,070

 

 
17,070

Restructuring charges
406

 

 
406

 
4,886

 

 
4,886

Total costs and operating expenses
$
1,059,460

 
$

 
$
1,059,460

 
$
867,889

 
$

 
$
867,889

The effect of the revisions to the selected quarterly financial results reflected above, is as follows for the year ended December 31, 2012 (in thousands):

 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
Year ended December 31, 2012:
 
 
 
 
 
 
 
Cost of revenue, as previously reported
$
102,566

 
$
107,457

 
$
109,995

 
$
111,893

Adjustment
22,359

 
23,803

 
24,226

 
27,601

Cost of revenue, as revised
$
124,925

 
$
131,260

 
$
134,221

 
$
139,494

Schedule of Unaudited Quarterly Financial Results
(in thousands, except per share data)
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
Year ended December 31, 2013:
 
 
 
 
 
 
 
Revenue
$
368,046

 
$
378,106

 
$
395,790

 
$
435,980

Cost of revenue
120,392

 
124,705

 
132,039

 
133,951

Net income
71,487

 
61,895

 
79,756

 
80,349

Basic net income per share
0.40

 
0.35

 
0.45

 
0.45

Diluted net income per share
0.39

 
0.34

 
0.44

 
0.44

Year ended December 31, 2012:
 
 
 
 
 
 
 
Revenue
$
319,448

 
$
331,306

 
$
345,321

 
$
377,872

Cost of revenue
124,925

 
131,260

 
134,221

 
139,494

Net income
43,227

 
44,239

 
48,231

 
68,292

Basic net income per share
0.24

 
0.25

 
0.27

 
0.38

Diluted net income per share
0.24

 
0.24

 
0.27

 
0.38